Praxis Precision stock rises as $575 million share sale clears at $260
NEW YORK, Jan 7, 2026, 12:02 PM EST — Regular session Praxis Precision Medicines shares rose about 6% on Wednesday after the biotech priced a $575 million public offering overnight, even as the deal came at a discount to the prior close. GlobeNewswire The Boston-based company late Tuesday set the offering at $260 per share for 2.212 million shares, and gave underwriters a 30-day option to buy up to 331,800 more shares. The deal is expected to close on or about Jan. 8, the company said. GlobeNewswire The stock was last at about $289.5 in midday trading, versus Tuesday’s close